ESC HF 21 Discussion: Vericiguat in Patients with AFIB and HF with HFrEF

Published: 12 Jul 2021

  • Views:

    Views Icon 927
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

Late-breaker series host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) sits down with Prof Piotr Ponikowski, professor of cardiology, Acting Rector, Vice-Rector for Scientific Affairs and the Head of Department of Heart Diseases at Wrocław Medical University, Poland.

In this in-depth discussion on vericiguat in patients with atrial fibrillation and heart failure with reduced ejection fraction, Prof Ponikowski shares the concept and latest findings from the sub-study VICTORIA. What mechanism of action of vericiguat might be relied upon to make a difference in the treatment effect? What are the findings that should be further investigated?

Recorded remotely from Hamilton and Wrocław, 2021.

Videography:Mike Knight, Oliver Miles